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Abstract: Background: Dermatological diseases are among the primary causes of the demand for basic health care. Studies on 
the frequency of dermatoses are important for the proper management of health planning.
oBjectives: To evaluate the nosological and behavioral profiles of dermatological consultations in Brazil.
Methods: The Brazilian Society of Dermatology invited all of its members to complete an online form on patients who sought 
consultations from March 21–26, 2018. The form contained questions about patient demographics, consultation type accor-
ding to the patient’s funding, the municipality of the consultation, diagnosis, treatments and procedures. Diagnostic and 
therapeutic decisions were compared between subgroups. 
results: Data from 9629 visits were recorded. The most frequent causes for consultation were acne (8.0%), photoaging (7.7%), 
nonmelanoma skin cancer (5.4%), and actinic keratosis (4.7%). The identified diseases had distinct patterns with regard to 
gender, skin color, geographic region, type of funding for the consultation, and age group. Concerning the medical conducts, 
photoprotection was indicated in 44% of consultations, surgical diagnostic procedures were performed in 7.3%, surgical the-
rapeutic procedures were conducted in 19.2%, and cosmetic procedures were performed in 7.1%. 
study liMitations: Nonrandomized survey, with a sample period of one week.
conclusion: This research allowed us to identify the epidemiological profiles of the demands of outpatients for dermatologists 
in various contexts. The results also highlight the importance of aesthetic demands in privately funded consultations and the 
significance of diseases such as acne, nonmelanoma skin cancer, leprosy, and psoriasis to public health.
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INTRODUCTION
Dermatological diseases are frequent among those who seek 
health care and are among the initial causes of the demand for out-
patient services.1 Because they are often visible to others, they are 
a source of embarrassment and social rejection, leading to psycho-
logical suffering.2,3 Although certain dermatological diseases can be 
treated in the primary care setting, many require specialized care.4
A 2017 publication reported that in the US, the burden of 
dermatological diseases is high and that its direct and indirect costs 
are comparable with those of other diseases, such as diabetes and 
cardiovascular diseases. This tremendous expense is due to the im-
plementation of treatments—not to the diagnostic phase. Overall, 
1 in 4 individuals of all ages in the US were seen by a doctor for at 
least 1 skin disease in 2013. In 2013, skin diseases resulted in direct 
health costs of 75 billion USD and, indirectly, opportunity costs of 
11 billion USD in the US. 5   
Skin diseases place a huge burden on global health. Collec-
tively, skin conditions were the fourth leading cause of nonfatal dis-
ease burden, expressed in years lost due to disability, in 2010. Taking 
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into account the loss of health due to premature death, expressed in 
disability-adjusted life years (DALYs), skin is the 18th leading cause. 
Based on the distribution of dermatological diseases by age, DALYs 
peak between age 10 and 20 years due to acne and at age 60 years 
due to nonmelanoma skin cancers.1
However, there is a trend toward the nonvalorization of 
such diseases by those who are responsible for defining health care 
policies, due to the underestimation of their lethality and morbidity 
as a health problem. Several studies have shown that dermatologi-
cal diseases have a significant impact on the quality of life of those 
who are affected, especially those who are chronically ill, highlight-
ing the need for their valorization as a health issue by those who 
formulate public policies, because they are, in fact, valued by affect-
ed patients. Individuals with dermatological diseases perceive their 
health to be affected, feel limited in performing their daily tasks, 
and experience a loss of vitality, lowering their quality of life.6-14 Der-
matological diseases are therefore limiting, causing school and work 
absenteeism, and their carriers are more likely to experience anxiety 
and depression.3,15-17
Studies on the distribution of these diseases are important 
for the proper management of health planning, with regard to 
health plans and the Brazilian public health care system (SUS). 
The incorporation of new procedures, in association with an aging 
population, is contributing to the rise in the demand for and cost of 
care in dermatology.
In 2018, the Brazilian Society of Dermatology (SBD) con-
ducted a survey on diagnoses and procedures that were performed 
during dermatological consultations, advancing the initiative that 
was begun in 2006, when the nosological profile of consultations 
was published.18
METHODS
The SBD invited all 8800 dermatologists who were current 
members to participate in the study, which consisted of the comple-
tion of an online form on all patients who were treated from May 
21–26, 2018—the same week of the study that was conducted in 
2006.18 The form included the patient’s age, gender, and skin color; 
city and state size; ICD-10 diagnosis; and their procedures.
For the analysis, certain related diseases were grouped, 
such as all superficial fungal infections, contact dermatitis, nonmel-
anoma skin cancers (basal cell and squamous cell carcinoma), and 
the ectoparasitoses. We also created the category “Others,” which 
incorporated the diagnoses that were to be elucidated and those 
diseases with an occurrence of less than 10 cases in the sample.
The main outcome was the frequency of diagnoses that 
were established at each consultation. Multinomial confidence in-
tervals (95%) were calculated from 10,000 bootstrap replications.19
To evaluate the statistical significance of the univariate 
analyses of the diagnoses by gender, we applied Spearman’s rank 
correlation coefficient to the entire set of diagnoses from each table.
To examine the association of known variables with fre-
quent and important diagnoses with regard to public health, we hy-
pothesized a case control study with an outpatient basis, in which 
the main diagnosis corresponded to the cases, while the other di-
agnoses corresponded to the controls. We then estimated the as-
sociation, based on the adjusted odds ratio by multivariate logistic 
regression.  20  
The study was approved by the research ethics committee 
of UNESP (nº 2.668.226).
RESULTS
Eight hundred eighty-five dermatologists completed the 
survey, which corresponds to 10% of the members of the Society at 
the time. Data were collected from 9629 consultations, with 13,293 
diagnoses, wherein 61.9% of patients had only 1 diagnosis, 29.7% 
had 2, 7.7% had 3, and 0.7% had 4.
The 9629 patients had a mean (standard deviation) age of 42.8 
(21.1) years (Figure 1); 65.1% (6266) was female, and 68.6% (6601) was 
Caucasian. Regarding funding for the consultation, 48.7% (4685) was 
financed by health plans, 25.0% (2409) was privately (out of pocket) 
funded, and 26.3% (2535) was funded by the SUS.
Table 1 shows the 60 most frequent diagnoses in the con-
sultations, corresponding to 98.3% of attended cases. Acne was the 
most frequent diagnosis (8.0%), followed by photoaging (7.7%), 
nonmelanoma skin cancer (6.6%), actinic keratosis (4.7%), and su-
perficial mycoses (4.5%).
Tables 2 to 7 present the leading 10 causes by age group, 
skin color, gender, type of funding for the consultation, type of con-
sultation (first or second appointment) , and demographic region. 
In these tables, differences were statistically significant between age 
groups, genders, and types of funding for consultation; there was no 
significance between the classifications by phototype, type of con-
sultation, and demographic region. 
Figure 2 shows the age histograms of the frequency of atop-
ic dermatitis, acne, nonmelanoma skin cancer, and photoaging; 
Figure 3 shows the age histograms for superficial mycoses, leprosy, 
actinic keratosis, and psoriasis.
With regard to skin color, diagnoses of photoaging (9.5%), 
nonmelanoma skin cancer (8.5%), and acne (8.3%) were more fre-
quent among whites, compared with acne (7.4%), superficial myco-
ses (5.8%), and melasma (5.5%), in non-whites. Although acne was 
the third most common condition in whites, its frequency was high-
er among non-whites. This phenomenon resulted non-significant 
regarding the ordination (rank) distribution, although diagnoses 
of photoaging and nonmelanoma skin cancer were more frequent 
among whites.













1 Acne 771 8.0 7.5 -8.6
2 Photoaging /Skin aging 746 7.7 7.2-8.3
3 Nonmelanoma skin cancer 633 6.6 6.1-7.1
4 Actinic keratosis / Actinic 
cheilitis
451 4.7 4.3-5.1




6 Psoriasis 421 4.4 4.0-4.8
7 Melasma 357 3.7 3.3-4.1
8 Others** 349 3.6 3.3-4.1
9 Melanocytic nevus 333 3.5 3.1-3.8
10 Atopic dermatitis 326 3.4 3.0-3.8
11 Contact dermatitis (allergic, 
irritant)
325 3.4 3.0-3.7
12 Male or female pattern andro-
genetic alopecia
307 3.2 2.8-3.5
13 Seborrheic keratosis 300 3.1 2.8-3.5
14 Acne in adult women 250 2.6 2.3-2.9
15 Seborrheic dermatitis 223 2.3 2.0-2.6
16 Viral wart 207 2.1 1.9-2.5
17 Telogen effluvium 196 2.0 1.8-2.3
18 Epidermal cyst / trichilemmal cyst 169 1.8 1.5-2.0
19 Acrochordon (skin tag) / mol-
luscum pendulum
167 1.7 1.5-2.0
20 Vitiligo 158 1.6 1.4-1.9
21 Leprosy 137 1.4 1.2-1.7
22 Rosacea 124 1.3 1.1-1.5
23 Alopecia areata 120 1.2 1.0-1.5
24 Folliculitis 110 1.1 0.9-1.4
25 Cutaneous xerosis / Asteatosis 106 1.1 0.9-1.3
26 Hypertrophic scar/Keloid 97 1.0 0.8-1.2
27 Lichen simplex chronicus/ 
Prurigo / Chronic eczema
94 1.0 0.8-1.2
28 Pruritus (sine materiae) 85 0.9 0.7-1.1
29 Scabies / Pediculosis 84 0.9 0.7-1.1
30 Solar lentigo / Solar melanosis 83 0.9 0.7-1.1
31 Cicatricial alopecia (lupus, 
folliculitis decalvans, lichen 
planus pilaris)
82 0.9 0.7-1.0
table 1: Main diagnoses of dermatological consultations (n = 9629)
Diagnosis N % 95% 
CI*
32 Urticaria /Angioedema 73 0.8 0.6-0.9
33 Molluscum contagiosum 71 0.7 0.6-0.9




36 Cutaneous lupus erythema-
tosus
60 0.6 0.5-0.8
37 Striae distansae 58 0.6 0.5-0.8
38 Chronic lower limb ulcer 58 0.6 0.4-0.8
39 Impetigo and ecthyma 55 0.6 0.4-0.7
40 Drug eruptions 53 0.6 0.4-0.7
41 Onycholysis /Onychomadesis/ 
Onychomalacia / Onychody- 
strophy
53 0.6 0.4-0.7
42 Acne scar 49 0.5 0.4-0.7
43 Pemphigus and pemphigoid 46 0.5 0.3-0.6
44 Anogenital warts (HPV) / 
Condyloma
44 0.5 0.3-0.6
45 Keratosis pilaris 43 0.4 0.3-0.6
46 Cutaneous lymphoma and lym-
phomatoid proliferations
42 0.4 0.3-0.6
47 Lipoma 41 0.4 0.3-0.6
48 Cutaneous / systemic sclero-
derma
37 0.4 0.3-0.5
49 Pityriasis rosea 34 0.4 0.2-0.5
50 Herpes zoster 31 0.3 0.2-0.4
51 Ingrown toenail / Onychoc-
ryptosis
30 0.3 0.2-0.4
52 Dermatofibroma 29 0.3 0.2-0.4
53 Genital / extralabial herpes 25 0.3 0.2-0.4
54 Hidradenitis suppurativa 24 0.2 0.2-0.4
55 Pityriasis  alba 22 0.2 0.1-0.3
56 Subcutaneous / Systemic 
mycosis
21 0.2 0.1-0.3
57 Syringoma / Sweat glands 
neoplasms
20 0.2 0.1-0.3
58 Lichen planus 19 0.2 0.1-0.3
59 Hemangioma 18 0.2 0.1-0.3
60 Syphilis 17 0.2 0.1-0.3
Diagnosis N % 95% 
CI*
* 95% CI: 95% confidence interval calculated from 10,000 bootstrap replications; ** Diagnoses with fewer than 10 occurrences or to be clarified
Between genders, women were most frequently diagnosed 
with photoaging (10.9%) and acne (6.2%), versus acne (11.4%) and 
nonmelanoma skin cancer (9.3%) in men, confirming that the de-
mand for dermatological care for aesthetic reasons is greater in fe-
males.
Regarding infectious diseases, the most frequent diagnosis 
was superficial mycoses, with 437 cases (4.5%). Moreover, 44 (0.5%) 
patients had a diagnosis of genital warts, 137 (1.4%) had leprosy, 
61 (0.6%) had syphilis, 84 (0.9%) had scabies / pediculosis, and 71 
(0.7%) had molluscum contagiosum.
918 Miot HA, Penna GO, Ramos AMC, Penna MLF, Schmidt SM, Luz FB, et al.
An Bras Dermatol. 2018;93(6):916-28.
table 2: Primary diagnoses by age group
0-12 years old  12-24 years old
Diagnosis N % Diagnosis N %
1 Atopic dermatitis 212 25.8 Acne 557 41.2
2 Molluscum contagiosum 61 7.4 Contact dermatitis 58 4.3
3 Viral wart 55 6.7 Atopic dermatitis 55 4.1
4 Acne 48 5.8 Superficial mycosis 49 3.6
5 Others 34 4.1 Melanocytic nevus 42 3.1
6 Superficial mycosis 32 3.9 Psoriasis 40 3.0
7 Melanocytic nevus 32 3.9 Viral wart 34 2.5
8 Scabies / Pediculosis 29 3.5 Others 32 2.4
9 Vitiligo 29 3.5 Striae distensiae 31 2.3
10 Alopecia areata 24 2.9 Male or female pattern andro genetic alopecia  31 2.3
11 Seborrheic dermatitis 20 2.4 Seborrheic dermatitis 28 2.1
12 Contact dermatitis 19 2.3 Acne in adult women 28 2.1
13 Impetigo and ecthyma 18 2.2 Telogen effluvium 24 1.8
14 Psoriasis 18 2.2 Alopecia areata 23 1.7
15 Hemangioma 14 1.7 Folliculitis 20 1.5
16 Diaper dermatitis 14 1.7 Vitiligo 19 1.4
17 Pityriasis alba 14 1.7 Hypertrophic scar 19 1.4
18 Lichen simplex chronicus 12 1.5 Scabies / Pediculosis 15 1.1
19 Xerosis / Asteatosis 11 1.3 Epidermoid cysts 15 1.1
20 Keratosis pilaris 9 1.1 Urticaria 14 1.0
25-59 years old 60 years and older 
Diagnosis N % Diagnosis N %
1 Photoaging 540 10.5 Nonmelanoma skin cancer 446 19.3
2 Melasma 341 6.6 Actinic keratosis 299 12.9
3 Psoriasis 251 4.9 Photoaging 202 8.7
4 Superficial mycosis 244 4.7 Seborrheic keratosis 144 6.2
5 Melanocytic nevus 225 4.4 Psoriasis 112 4.8
6 Male or female pattern andro genetic 
alopecia
221 4.3 Superficial mycosis 112 4.8
7 Acne in adult women 220 4.3 Contact dermatitis 78 3.4
8 Others 208 4.0 Others 75 3.2
9 Nonmelanoma skin cancer 179 3.5 Male or female pattern andro genetic alopecia   52 2.3
10 Contact dermatitis 170 3.3 Pruritus (sine materiae) 44 1.9
11 Acne 156 3.0 Acrochordon /skin tag 42 1.8
12 Seborrheic keratosis 149 2.9 Epidermoid cysts 42 1.8
13 Actinic keratosis 149 2.9 Lower limb ulcer 38 1.6
14 Seborrheic dermatitis 143 2.8 Xerosis / Asteatosis 35 1.5
15 Telogen effluvium 141 2.7 Melanocytic nevus 34 1.5
16 Acrochordon /skin tag 116 2.3 Seborrheic dermatitis 32 1.4
17 Epidermoid cysts 109 2.1 Leprosy 32 1.4
18 Vitiligo 95 1.8 Rosacea 30 1.3
19 Viral wart 90 1.7 Solar lentigo / Solar melanosis 30 1.3
20 Leprosy 88 1.7 Telogen effluvium 29 1.3
Spearman rank R: -0.07 t=-7.23 p<0.01
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table 3: Main diagnoses by skin color
 COLOR - White  COLOR - Non-white 
Diagnosis N % Diagnosis N %
1 Photoaging 628 9.5 Acne 225 7.4
2 Nonmelanoma skin cancer 564 8.5 Superficial mycosis 175 5.8
3 Acne 546 8.3 Melasma 168 5.5
4 Actinic keratosis 418 6.3 Psoriasis 159 5.3
5 Melanocytic nevus 281 4.3 Atopic dermatitis 128 4.2
6 Superficial mycosis 262 4.0 Photoaging 118 3.9
7 Psoriasis 262 4.0 Contact dermatitis 116 3.8
8 Others 246 3.7 Others 103 3.4
9 Seborrheic keratosis 215 3.3 Acne in adult women 97 3.2
10 Male or female pattern andro genetic 
alopecia 
211 3.2 Seborrheic dermatitis 97 3.2
11 Contact dermatitis 209 3.2 Male or female pattern andro genetic alopecia 96 3.2
12 Atopic dermatitis 198 3.0 Leprosy 91 3.0
13 Melasma 189 2.9 Seborrheic keratosis 85 2.8
14 Acne in adult women 153 2.3 Acrochordon   / skin tag 70 2.3
15 Viral wart 142 2.2 Nonmelanoma skin cancer 69 2.3
16 Telogen effluvium 138 2.1 Viral wart 65 2.1
17 Seborrheic dermatitis 126 1.9 Epidermoid cysts 63 2.1
18 Rosacea 113 1.7 Telogen effluvium 58 1.9
19 Epidermoid cysts 106 1.6 Vitiligo 58 1.9
20 Vitiligo 100 1.5 Alopecia areata 56 1.8
table 4: Distribution of diagnoses by gender
Female  Male 
Diagnosis N % Diagnosis N %
1 Photoaging 682 10.9 Acne 385 11.4
2 Acne 386 6.2 Nonmelanoma skin cancer 312 9.3
3 Melasma 335 5.3 Actinic keratosis 193 5.7
4 Nonmelanoma skin cancer 321 5.1 Superficial mycosis 192 5.7
5 Actinic keratosis 258 4.1 Psoriasis 180 5.4
6 Superficial mycosis 245 3.9 Atopic dermatitis 138 4.1
7 Acne in adult women 243 3.9 Melanocytic nevus 128 3.8
8 Psoriasis 241 3.8 Others 109 3.2
9 Others 240 3.8 Seborrheic dermatitis 105 3.1
10 Contact dermatitis 224 3.6 Contact dermatitis 101 3.0
11 Male or female pattern andro genetic 
alopecia
206 3.3 Androgenetic alopecia 101 3.0
12 Seborrheic keratosis 206 3.3 Seborrheic keratosis 94 2.8
13 Melanocytic nevus 205 3.3 Viral wart 86 2.6
14 Atopic dermatitis 188 3.0 Leprosy 76 2.3
15 Telogen effluvium 187 3.0 Acrochordon /skin tag 71 2.1
16 Viral wart 121 1.9 Photoaging 64 1.9
17 Seborrheic dermatitis 118 1.9 Alopecia areata 64 1.9
18 Vitiligo 115 1.8 Epidermoid cysts 61 1.8
19 Epidermoid cysts 108 1.7 Folliculitis 53 1.6
20 Acrochordon /skin tag 96 1.5 Vitiligo 43 1.3
Spearman rank R: 0.01 t=0.815 p=0.42.
Spearman rank R: -0.15 t=-15.00 p<0.01
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table 6: Distribution of diagnoses by type of consultation
FIRST APPOINTMENT SECOND APPOINTMENT 
Diagnosis N % Diagnosis N % 
1 Acne 386 8.2 Photoaging 260 9.9
2 Superficial  mycosis 282 6.0 Acne 386 7.9
3 Photoaging 260 5.5 Nonmelanoma skin cancer 255 7.7
4 Nonmelanoma skin cancer 255 5.4 Psoriasis 115 6.2
5 Contact dermatitis 202 4.3 Actinic keratosis 190 5.3
6 Atopic dermatitis 197 4.2 Others 160 3.9
7 Seborrheic keratosis 197 4.2 Melasma 170 3.8
8 Actinic keratosis 190 4.0 Male or female pattern andro genetic alopecia  140 3.4
9 Melanocytic nevus 189 4.0 Superficial mycosis 282 3.2
10 Melasma 170 3.6 Melanocytic nevus 189 2.9
11 Others 160 3.4 Atopic dermatitis 197 2.6
12 Seborrheic dermatitis 148 3.1 Contact dermatitis 202 2.5
13 Acne in adult women 146 3.1 Viral wart 90 2.4
14 Male or female pattern andro genetic 
alopecia
140 3.0 Acne in adult women 146 2.1
15 Telogen effluvium 120 2.5 Seborrheic keratosis 197 2.1
16 Psoriasis 115 2.4 Leprosy 36 2.1
17 Acrochordon  /  skin tag 99 2.1 Vitiligo 61 2.0
18 Epidermoid cysts 93 2.0 Telogen effluvium 120 1.6
19 Viral wart 90 1.9 Epidermoid cysts 93 1.6
20 Xerosis / Asteatosis 72 1.5 Seborrheic dermatitis 148 1.5
table 5: Distribution of diagnoses by type of funding for consultation
 COVERAGE / HEALTH INSURANCE PRIVATE / OUT OF POCKET PAYMENT  SUS / PUBLIC 
Diagnosis N % Diagnosis N % Diagnosis N %
1 Acne 497 10.6 Photoaging 495 20.5 Nonmelanoma skin cancer 297 11.7
2 Superficial mycosis 261 5.6 Acne 160 6.6 Psoriasis 225 8.9
3 Actinic keratosis 230 4.9 Nonmelanoma skin cancer 155 6.4 Leprosy 131 5.2
4 Melasma 227 4.8 Others 149 6.2 Actinic keratosis 128 5.0
5 Photoaging 201 4.3 Male or female pattern 
andro genetic alopecia 
114 4.7 Superficial mycosis 121 4.8
6 Seborrheic keratosis 200 4.3 Actinic keratosis 93 3.9 Acne 114 4.5
7 Melanocytic nevus 187 4.0 Contact dermatitis 88 3.7 Atopic dermatitis 90 3.6
8 Nonmelanoma skin cancer 181 3.9 Psoriasis 85 3.5 Others 83 3.3
9 Atopic dermatitis 179 3.8 Melasma 80 3.3 Melanocytic nevus 70 2.8
10 Acne in adult women 172 3.7 Melanocytic nevus 76 3.2 Vitiligo 68 2.7
11 Contact dermatitis 171 3.6 Atopic dermatitis 57 2.4 Contact dermatitis 66 2.6
12 Male or female pattern 
andro genetic alopecia 
154 3.3 Superficial mycosis 55 2.3 Seborrheic dermatitis 51 2.0
13 Seborrheic dermatitis 140 3.0 Acne in adult women 55 2.3 Photoaging 50 2.0
14 Acrochordon /skin tag 138 2.9 Seborrheic keratosis 51 2.1 Melasma 50 2.0
15 Telogen effluvium 137 2.9 Rosacea 46 1.9 Seborrheic keratosis 49 1.9
16 Viral wart 134 2.9 Telogen effluvium 39 1.6 Alopecia areata 45 1.8
17 Epidermoid cysts 124 2.6 Vitiligo 38 1.6 Chronic ulcer 42 1.7
18 Others 117 2.5 Seborrheic dermatitis 32 1.3 Viral wart 41 1.6
19 Psoriasis 111 2.4 Viral wart 32 1.3 Pemphigus and pemphigoid 41 1.6
20 Folliculitis 60 1.3  Cicatricial alopecia 30 1.2 Male or female pattern 
andro genetic alopecia 
39 1.5
Spearman Rank R: 0.01 t=0.95 p=0.34
Spearman rank R: -0.09 t=-8.52 p<0.01
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table 7: Distribution of diagnoses by region in Brazil
North Northeast Southeast
Diagnosis N % Diagnosis N % Diagnosis N %
1 Acne 110 7.6 Photoaging 52 10.9 Photoaging 374 8.6
2 Atopic dermatitis 72 5.0 Acne 38 8.0 Acne 336 7.7
3 Superficial mycosis 63 4.4 Leprosy 24 5.0 NM skin cancer 281 6.5
4 Melasma 63 4.4 NM skin cancer 23 4.8 Superficial mycosis 224 5.2
5 NM skin cancer 61 4.2 Melasma 20 4.2 Psoriasis 205 4.7
6 Others 56 3.9 Psoriasis 20 4.2 Actinic keratosis 186 4.3
7 Contact dermatitis 54 3.8 Superficial mycosis 18 3.8 Others 180 4.1
8 Photoaging 48 3.3 Atopic dermatitis 17 3.6 Melasma 154 3.5
8 Psoriasis 44 3.1 Seborrheic keratosis 17 3.6 Melanocytic nevus 149 3.4
10 Acrochordon /skin tag 44 3.1 Acne in adult women 16 3.4 Contact dermatitis 135 3.1
11 Seborrheic dermatitis 43 3.0 Male or female pattern 
andro genetic alopecia  
15 3.2 Atopic dermatitis 134 3.1
12 Scabies / Pediculosis 42 2.9 Actinic keratosis 15 3.2 Seborrheic keratosis 130 3.0
13 Male or female pattern 
andro genetic alopecia  
39 2.7 Seborrheic dermatitis 14 2.9 Male or female pattern 
andro genetic alopecia
129 3.0
14 Epidermoid cysts 39 2.7 Contact dermatitis 13 2.7 Acne in adult women 104 2.4
15 Acne in adult women 36 2.5 Acrochordon /skin tag 12 2.5 Viral wart 104 2.4
16 Melanocytic nevus 33 2.3 Melanocytic nevus 12 2.5 Seborrheic dermatitis 100 2.3
17 Seborrheic keratosis 30 2.1 Others 11 2.3 Telogen effluvium 89 2.0
18 Actinic keratosis 28 1.9 Epidermoid cysts 9 1.9 Epidermoid cysts 80 1.8
19 Telogen effluvium 26 1.8 Viral wart 9 1.9 Vitiligo 65 1.5
20 Viral wart 26 1.8 Telogen effluvium 8 1.7 Leprosy 62 1.4
South Midwest
Diagnosis N % Diagnosis N %
1 NM skin cancer 195 8.9 Acne 119 9.8
2 Photoaging 185 8.5 Photoaging 87 7.1
3 Actinic keratosis 171 7.8 NM skin cancer 73 6.0
4 Acne 168 7.7 Superficial mycosis 56 4.6
 5 Psoriasis 105 4.8 Male or female pattern andro genetic alopecia  55 4.5
6 Melanocytic nevus 100 4.6 Acne in adult women 54 4.4
7 Seborrheic keratosis 79 3.6 Contact dermatitis 51 4.2
8 Superficial mycosis 76 3.5 Actinic keratosis 51 4.2
9 Contact dermatitis 72 3.3 Melasma 49 4.0
10 Melasma 71 3.2 Psoriasis 47 3.9
11 Male or female pattern andro genetic 
alopecia 
69 3.2 Seborrheic keratosis 44 3.6
12 Others 66 3.0 Melanocytic nevus 39 3.2
13 Atopic dermatitis 65 3.0 Atopic dermatitis 38 3.1
14 Viral wart 52 2.4 Others 36 3.0
15 Vitiligo 51 2.3 Seborrheic dermatitis 30 2.5
16 Telogen effluvium 49 2.2 Acrochordon / skin tag 25 2.0
17 Rosacea 48 2.2 Alopecia areata 25 2.0
18 Acne in adult women 40 1.8 Telogen effluvium 24 2.0
19 Seborrheic dermatitis 36 1.6 Leprosy 21 1.7
20 Acrochordon /skin tag 30 1.4  Cicatricial alopecia 17 1.4
Spearman rank R: -0.01 t=-0.08 p=0.94
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FIgure 2: Age histograms 
for patients diagnosed with 
atopic dermatitis, acne, 
nonmelanoma skin cancer, 
and photoaging
FIgure 3: Age histograms 
for patients  diagnosed 
with superficial mycoses, 
Hansen disease, actinic 
keratosis, and psoriasis
When we considered all consultation-based diagnoses - not 
only the main diagnosis - the most relevant result was the increase in 
the proportion of patients who were affected by the most common 






years had a diagnosis of acne, and 24.1% of those aged 60 years and 
older had a diagnosis of nonmelanoma skin cancer, whereas these 
diseases were the chief diagnoses in the consultations in 41.2% and 
19.3% of the age groups above.
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Age (years)
table 8: Frequencies of (standard) treatments resulting from 
consultations
CONDUCT N % of patients
Topical Medications1 4922 51.1
Sunscreen 4232 44.0
Moisturizers and emollients 3002 31.2
Oral medications2 2379 24.7
Topical cosmeceuticals3 1859 19.3
Therapeutic surgical procedure4 1838 19.1
Diagnostic clinical procedure5 801 8.3
Diagnostic surgical procedure6 706 7.3
Cosmetic surgical procedure7 674 7.0
Nutraceuticals, antioxidants and food 
supplements
605 6.3




1. e.g., corticoid, antifungal, antimicrobial, tretinoin, minoxidil
2. e.g., antimicrobials, antihistamines, isotretinoin, immunosuppressants 
3. e.g., antioxidants, retinoids, soaps
4. e.g., electrocoagulation, excision and suturing, cryosurgery
5. e.g., dermatoscopy, Wood’s lamp, esthesiometer
6. e.g., biopsy, puncture, mycological examination
7. e.g., peeling, laser, needling, microdermabrasion
8. e.g., PUVA, NBUVB, PUVA sun
9. e.g., anti-TNF, anti-IgE, anti-IL17
Spearman rank R: 0.03 t=4.33 p<0.01
table 9: Frequencies of (standard) treatments by type of funding for consultation
CONDUCT / PRESCRIPTION Coverage / health insurance Private / Out of pocke SUS / public
N % of patients N % of patients N % of patients
1 All procedures 11741 250.6 6266 260.1 5474 215.9
2 Topical medications 2657 56.7 1045 43.4 1220 48.1
3 Sunscreen 2203 47.0 988 41.0 1041 41.1
4 Moisturizers and emollients 1456 31.1 672 27.9 874 34.5
5 Oral medications 1056 22.5 583 24.2 740 29.2
6 Topical cosmeceuticals 1128 24.1 525 21.8 206 8.1
7 Therapeutic surgical procedure 1012 21.6 349 14.5 477 18.8
8 Diagnostic clinical procedure 415 8.9 212 8.8 174 6.9
9 Diagnostic surgical procedure 338 7.2 126 5.2 242 9.5
10 Cosmetic surgical procedure 181 3.9 432 17.9 61 2.4
11 Nutraceuticals and antioxidants 355 7.6 213 8.8 37 1.5
12 Botulinum toxin 134 2.9 381 15.8 9 0.4
13 Fillers/volumizers 79 1.7 222 9.2 2 0.1
14 Phototherapy 43 0.9 46 1.9 60 2.4
15 Immunobiologicals 14 0.3 18 0.7 33 1.3
Table 8 shows the most frequent standard treatments and 
the proportion of patients to whom they were administered.  Table 9 
shows the practices and the proportion of patients by funding type. 
Notably, each patient received more than 1 treatment, for example, 
2.51 indications on average in consultations funded by health plans, 
compared with 2.61 for private funding and 2.16 for SUS-funded 
consultations.
Table 10 presents the results of the logistic regression, com-
paring certain diseases by region in Brazil, gender, age group, and 
funding type. Leprosy was associated with regional differences, a 
preponderance of SUS-based care, males the working age group, 
non-white skin color, and the need for subsequent appointments. 
The frequency of psoriasis was higher in the south of Brazil, those 
in the public health care system, males, the economically produc-
tive age group, and those who required return visits. Nonmelano-
ma skin cancers were more common in those who were on public 
assistance, males, resident of smaller towns, and those with white 
skin color.
DISCUSSION
Dermatology, as a medical specialty, typically encompasses 
a high number of nosological entities from skin, mucosae and skin 
appendages. In parallel, it assists many populations, enclosing all 
age groups and genders, which, added to the sociocultural, climatic, 
and ethnic differences of the Brazilian population, results in indi-
vidualized patterns of disease occurrence.21 All of these elements 
should be weighed in planning specialty care, public health policies, 
and medical education.22-26
The most frequent primary diagnosis of the consultations 
in our study was acne, as well as in a previous report from 2006.18 
Actually, acne is the main cause for consultations in Saudi Arabia27 
and the US.28 In a study with dermatologists in Spain,4 the most fre-
quent diagnosis was nonmelanoma skin cancer, although acne was 
the chief diagnosis among those aged under 18 years. The inconsis-
tency between our results and those in Spain is due to the disparate 
age groups between study populations.
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* OR: odds ratio
table 10: Multivariate analysis (multiple logistic regression) comparing the frequency of Hansen disease, psoriasis, and 
nonmelanoma skin cancer by region in Brazil, gender, age group, city size, skin color, funding type, and consultation type
LEPROSY PSORIASIS NONMELANOMA CA
OR* p OR* p OR* p
Region N 2.07 0.02 0.78 0.37 1.62 0.07
NE 4.52 0.00 0.83 0.70 1.30 0.95
S 0.25 0.00 1.16 0.02 1.22 0.60
MW 1.24 0.99 0.74 0.17 1.35 0.66
SE  1  1  1 
Funding type Coverage / health insurance 0.01 0.00 0.31 0.00 0.32 0.00
Private /out of pocket payment 0.03 0.03 0.42 0.03 0.42 0.01
SUS  1  1  1 
Gender Female 0.44 0.00 0.69 0.00 0.50 0.00
 Male  1  1  1 
Age group (years) 0-12 0.30 0.02 0.50 0.01 0.02 0.00
13-24 0.78 0.95 0.72 0.37 0.02 0.00
25-59 1.50 0.00 1.24 0.00 0.19 0.00
>60  1  1  1 
City <100,000 inhabitants 0.74 0.53 0.57 0.24 1.62 0.01
100-300,000 inhabitants 1.07 0.54 0.54 0.05 1.24 0.86
>300,000 inhabitants  1  1  1 
Skin color White 0.53 0.01 0.85 0.15 3.94 0.00
Non-white  1 
Consultation type First appointment 0.51 0.00 0.47 0.00 0.98 0.83
Second appointment  1  1  1 
Differences in the occurrence of conditions between ages 
are expected and are characteristic of the natural history of derma-
toses, such as ectoparasitoses and childhood viral infections, in con-
trast to melasma and acne in adult women and nonmelanoma skin 
cancers and seborrheic keratosis among the elderly.29-33 Chronic dis-
eases, such as psoriasis and androgenetic alopecia, tend to increase 
progressively in frequency, depending on the age group.21,34-36 Con-
versely, more limited diseases, such as acne and atopic dermatitis, 
become less common in adulthood. Superficial mycoses, in contrast, 
are frequent in all age groups.
The skin is an organ that interfaces directly with the envi-
ronment, and external insults can promote several dermatoses. The 
ethnic and climatic variety in Brazil is considered in the type of epi-
demiological examination that we performed in this study. Contact 
dermatitis became frequent in consultations, especially beginning 
in adolescence, when work activities initiate. Nonmelanoma skin 
cancer and actinic keratoses were frequent among the elderly, es-
pecially those with light skin color who were treated by the public 
health system, reflecting chronic exposure to ultraviolet radiation in 
such activities as agriculture and fishing.35, 37, 38  Melasma was typical 
in women and non-white adult patients, due to the role of female 
hormones and miscegenation in its pathogenesis.32, 38-41  
In comparing our results with those of the 2006 study, which 
used only the general ICD-10 category codes, a major difference arose 
between the two sets of patients with regard to the inclusion of pa-
tients with a primary diagnosis of photoaging, which reflects the cos-
metic demand for dermatologists, especially in private consultations 
and among white women. When using the same type of coding as 
in the previous study, a diagnosis of acne (L70) was given to 10.6% 
(1021) of patients, whereas skin alterations due to chronic exposure 
to non-ionizing radiation (L57) was diagnosed in 12.4% (1197) of pa-
tients, versus 14.0% and 5.1% in the 2006 study, respectively.
Notably, in our study, superficial mycoses were the fifth 
most frequent diagnosis (4.5%) compared with the second most com-
mon diagnosis in the 2006 study (8.7%). This difference is attributed 
to the finding that in SUS-funded patients, this was the main diagno-
sis in 2006 (9.8%) but remained the fifth most frequent diagnosis in 
our subjects (4.8%) (Table 5), likely reflecting a greater capacity for 
diagnosis and treatment for basic care in the SUS system.
Psoriasis was the tenth most frequent diagnosis in 2006 
(2.5% of patients) but the sixth most frequent cause of consultations 
(4.4%) in 2018. This increase is likely due to greater awareness by the 
patients, generating greater demand for diagnosis and better adher-
ence to treatment.42 Disease chronicity, associated with population 
aging, also contributes to the increased need for specialized care.43,44 
The distribution of diagnoses between regions reflects the survey 
of capital cities in 2014, in which psoriasis was more prevalent in 
the south and southeast.34 Our regional differences in the rates of 
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vitiligo, leprosy, and hidradenitis suppurativa also reproduced the 
findings of population-based studies in Brazil, which might be at-
tributed to the regional ethnic composition.45-48
The differences in diagnoses regarding funding source 
(public, health insurance, and out of pocket payment) reflect the 
socioeconomic variation in patients and the need for referrals to 
specialists in comparing those who are covered by SUS and health 
insurance. Regarding socioeconomic differences, leprosy constitut-
ed 5.2% of diagnoses in SUS subjects (third most frequent) but was 
absent from the 20 most frequent diagnoses in health insurance and 
private consultations. The initial cause in diagnoses among private 
consultations was photoaging, with 20.5% of diagnoses, demon-
strating the importance of the demand for cosmetic consultations in 
self-financed private practice. This pattern is reflected in the proce-
dures that were performed, wherein the use of botulinum toxin and 
fillers was much more prevalent in private versus SUS and health 
insurance consultations. There were also more prescriptions for 
topical cosmeceuticals among insurance-based consultations (24.1% 
of patients) and for private patients (21.8%).
Before we discuss the logistic regression results, we must 
highlight the proposal to consider the data as a case control study—
ie, considering the diagnoses for leprosy (and psoriasis and nonmel-
anoma cancer, analyzed separately) as “cases” and the other diagno-
ses as their “controls,” assuming that these groups are comparable 
if their selection has not been biased. To have a bias, the selection 
of the patient pool should alter the proportion of cases and other 
aspects of interest (eg, age, gender, region in Brazil). The regres-
sion results, expressed as odds ratios as a measure of association, 
are controlled by other items (covariables) that are included. These 
non-biased results can be extrapolated to the general population.
Leprosy and psoriasis were more frequent in second ap-
pointments, which is consistent with the fact that they are chronic 
diseases. As expected, the risk of leprosy was greater among the 
population that was covered by the SUS, males, non-whites, and 
those aged over 24 years. Unexpectedly, the northeast region of 
Brazil was at greater risk than those in the midwest, in contrast 
to published epidemiological data, although the detection rates in 
northeast have risen significantly.47,48 Another interpretation is that 
there was selection bias, because the northeast region was the least 
adherent in this study.
By regression analysis, there was a higher risk of psoriasis 
consultations in the southern region, the SUS-covered population, 
and those aged between 25 and 59 years, whereas for non-melano-
ma cancers, there was no statistically significant difference between 
regions, with a higher risk among those aged over 60 years and cit-
ies with fewer than 100,000 inhabitants. The latter association - a 
greater risk for cities - can be explained by such cities harboring 
populations with a history of outdoor work, such as agriculture and 
livestock.30,37
Finally, it is important to highlight the high proportion of 
patients with prescriptions for sunscreen (44%), which demon-
strates a preventive approach and an attitude toward health educa-
tion that are adopted by professionals.49 Diagnostic and therapeutic 
surgical procedures were indicated in 26.4% of visits, highlighting 
the prevalence of such methods in the actual clinical practice of Bra-
zilian dermatologists.
Cosmetic/aesthetic procedures, such as the application of 
botulinum toxin and fillers, were more frequent among private con-
sultations than those that were funded by health insurance or the 
SUS. Conversely, prescriptions for immunobiologicals were more 
common in SUS-based consultations, although it is unusual (1.3% 
of SUS patients, 0.7% of private patients, and 0.3% of health insur-
ance-covered patients), likely reflecting their high cost, which is de-
pendent on public funding.
The study limitations primarily concern the lack of random-
ization due to the spontaneous and heterogeneous adherence of 
dermatologists; however, all covariates (demographic, geography, 
and care) were considered. Another limitation was that the sample 
comprised only one epidemiologic week, which might have influ-
enced the frequency of diseases with seasonal characteristics, such 
as psoriasis, leishmaniasis, and mycoses.50 Nevertheless, the same 
epidemiological week was chosen as in the 2006 study to allow com-
parisons to be made, constituting the main source of information on 
the demand for dermatological services in Latin America. 
CONCLUSION
This research has allowed us to determine the epidemio-
logical profile of outpatient demand for Brazilian dermatologists in 
various contexts. The results also highlight the importance of the 
demand for surgical and cosmetic procedures for private consul-
tations and the significant of such diseases as nonmelanoma skin 
cancer, leprosy, and psoriasis to the public health. q
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